Weight Gain in Bipolar Disorder: Pharmacological Treatment As a Contributing Factor

Overview

Journal Acta Psychiatr Scand

Specialty Psychiatry

Date 2008 May 24

PMID 18498432

Citations 38

Authors

C Torrent

B Amann

J Sanchez-Moreno

F Colom

M Reinares

M Comes

A R Rosa

J Scott

E Vieta

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this paper was to review the association of most commonly used psychopharmacological drugs with weight gain in bipolar disorder.

Method: Information was retrieved from a PubMed/Medline literature search reviewing weight gain in pharmacological studies in bipolar disorder.

Results: Obesity and overweight in bipolar disorder are partly related to prescribed drugs with a strong effect of clozapine and olanzapine. Lesser but still relevant weight gain is caused by quetiapine, risperidone, lithium, valproate, gabapentin and by some antidepressants. Ziprasidone, aripiprazole, carbamazepine and lamotrigine do not seem to cause significant overweight.

Conclusion: Careful monitoring of weight changes in patients before and after drug prescription should be implemented in the clinical routine and drugs which potentially cause weight gain should be avoided in overweight patients with bipolar disorder. Furthermore, eating habits and daily activities should be targeted as they may also have a significant impact on overall health and weight-related issues.

Citing Articles

Are Adults With Bipolar Disorder at Increased Cardiovascular Risk due to Their Physical, Biochemical, and Physiological Profiles? The FINEXT-BD Study.

Etxaniz-Oses J, Maldonado-Martin S, Zorrilla I, Gorostegi-Anduaga I, Apodaca-Arrizabalaga M, Gonzalez-Pinto A Brain Behav. 2025; 15(2):e70297.

PMID: 39924971 PMC: 11808178. DOI: 10.1002/brb3.70297.

Predicting remission after acute phase pharmacotherapy in patients with bipolar I depression: A machine learning approach with cross-trial and cross-drug replication.

Marrero-Polanco J, Joyce J, Grant C, Croarkin P, Athreya A, Bobo W Bipolar Disord. 2024; 27(1):36-46.

PMID: 39362832 PMC: 11848014. DOI: 10.1111/bdi.13506.

Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial.

Xie P, Shao T, Long Y, Xie W, Liu Y, Yang Y Lipids Health Dis. 2024; 23(1):225.

PMID: 39049073 PMC: 11267745. DOI: 10.1186/s12944-024-02214-w.

Long-term weight loss outcomes after bariatric surgery: a propensity score study among patients with psychiatric disorders.

Dupont L, Alves A, Bui E, Lee Bion A, Meunier H, Briant A Surg Endosc. 2023; 37(11):8362-8372.

PMID: 37700014 DOI: 10.1007/s00464-023-10343-z.

The network structure of mania symptoms differs between people with and without binge eating.

Davies H, Peel A, Mundy J, Monssen D, Kakar S, Davies M Bipolar Disord. 2023; 25(7):592-607.

PMID: 37308319 PMC: 10768381. DOI: 10.1111/bdi.13355.